Invention Grant
- Patent Title: Glucagon like peptide 1 (GLP-1) fusion peptide coupled cyclic peptide tyrosine tyrosine conjugates and uses thereof
-
Application No.: US15733776Application Date: 2019-04-24
-
Publication No.: US11780900B2Publication Date: 2023-10-10
- Inventor: Yue-Mei Zhang , Raul Camacho , Martin A. Case , Ellen Chi , Suzanne Edavettal , Wilson Edwards , Lisa Norquay , Mark J. Wall , Rui Zhang , Songmao Zheng
- Applicant: Janssen Sciences Ireland Unlimited Company
- Applicant Address: IE Cork
- Assignee: Janssen Sciences Ireland Unlimited Company
- Current Assignee: Janssen Sciences Ireland Unlimited Company
- Current Assignee Address: IE Cork
- Agency: Seed IP Law Group LLP
- International Application: PCT/IB2019/053384 2019.04.24
- International Announcement: WO2019/207505A 2019.10.31
- Date entered country: 2020-10-22
- Main IPC: C07K14/605
- IPC: C07K14/605 ; A61K47/66 ; A61P3/06 ; A61P5/50 ; C07K7/64 ; A61P3/10 ; A61K47/64 ; A61P3/04 ; A61K9/00 ; C07K14/575 ; A61K38/00
Abstract:
The present invention comprises conjugates comprising a glucagon-like peptide 1 (GLP-1) fusion peptide coupled to a cyclic PYY peptide. The invention also relates to pharmaceutical compositions and methods for use thereof. The novel conjugates are useful for preventing, treating or ameliorating diseases and disorders disclosed herein.
Public/Granted literature
Information query
